Concepedia

Bishwajit Nag

BN

Statistics

Publications

30

Citations

770

H-Index

18

Active since

1983

Affiliations

Synergia (United States)(Current)

Maxygen (United States)

University of California, Davis

Codexis (United States)

California State University System

Bishwajit Nag is an author at Synergia (United States) specializing in life sciences, immunology, and major histocompatibility complex.

Publications per year

1983–2003

30

Publications

30

Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.

Suresh D. Sharma, Bishwajit Nag, Xiaojie Su et al. · Proceedings of the National Academy of Sciences · 1991 · 104 citations

, , +17

Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.

Michael Nicolle, Bishwajit Nag, Suresh D. Sharma et al. · Journal of Clinical Investigation · 1994 · 77 citations · Full text

, , +17

Synthesis and structure–Activity relationship studies of cinnamic acid-based novel thiazolidinedione antihyperglycemic agents

Partha Neogi, Fredrick J Lakner, Satyanarayana Medicherla et al. · Bioorganic & Medicinal Chemistry · 2003 · 50 citations

, , +11

Induction of tolerance in experimental autoimmune myasthenia gravis with solubilized MHC class II: Acetylcholine receptor peptide complexes

Edward G. Spack, M McCutcheon, Nancy L. Corbelletta et al. · Journal of Autoimmunity · 1995 · 42 citations

, , +11

Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells

Bishwajit Nag, Hiroshi Wada, David Passmore et al. · The Journal of Immunology · 1993 · 32 citations · Full text

, , +17

1–5 of 30